NCT01267656CompletedNot Applicable
Study to Evaluate the Product Feasibility of a Contact Lens Lubricating and Rewetting Drop
Bausch & Lomb Incorporated2 sites in 1 country168 target enrollmentStarted: October 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Bausch & Lomb Incorporated
- Enrollment
- 168
- Locations
- 2
- Primary Endpoint
- Percentage of Eyes With Graded Slit Lamp Findings Greater Than Grade 2.
Study Overview
Brief Summary
The objective of this study is to evaluate the product performance of investigational lubricating and rewetting drops.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Screening
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- •Adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
- •Use a lens care system on a regular basis.
- •Wear their habitual lenses (or be willing to wear lenses) a minimum of 8 hours per day.
- •Willing to use drops 4 times per day.
Exclusion Criteria
- •Participating in a conflicting study.
- •An active ocular disease, any corneal infiltrative response, or are using any ocular medications.
- •Any scar or neovascularization within the central 4mm of the cornea.
- •Any grade 2 or greater finding during the slit lamp examination
- •Using any systemic or topical medications that will affect ocular physiology or lens performance.
- •Amblyopic.
- •Allergic to any component in the study care products.
- •Have had any corneal surgery.
Outcomes
Primary Outcomes
Percentage of Eyes With Graded Slit Lamp Findings Greater Than Grade 2.
Time Frame: At 1 week follow up
Slit lamp findings for epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded 0 to 4, with 0 = none to 4 = severe. The outcome measure is any finding \> grade 2, across abnormalities.
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Feasibility of a New Silicone Hydrogel LensMyopiaNCT01131130Bausch & Lomb Incorporated120
Completed
Not Applicable
Evaluation of a New Silicone Hydrogel Contact LensMyopiaNCT01309880Bausch & Lomb Incorporated66
Completed
Not Applicable
Product Feasibility of a New Silicone Hydrogel Contact LensMyopiaNCT01309100Bausch & Lomb Incorporated144
Completed
Not Applicable
Evaluation of the Feasibility a New Silicone Hydrogel Contact LensMyopiaNCT01309906Bausch & Lomb Incorporated66
Completed
Not Applicable
A Study to Evaluate a New Silicone Hydrogel Contact LensMyopiaNCT01309893Bausch & Lomb Incorporated66